Eli Lilly and Company (NYSE: LLY) is making a confident and distinctly forward-looking move beyond its blockbuster obesity and diabetes franchises. Its agreement to acquire privately held Merida Biosciences for up to $2.875 billion in cash is a bullish vote for precision immunology:…
NVIDIA’s blockbuster fiscal Q2 2027 earnings reinforced its position at the center of the global AI infrastructure boom. With record data-center revenue, accelerating demand for Blackwell and Vera Rubin systems, and a rising sovereign-AI opportunity, NVIDIA (NASDAQ: NVDA) is expanding from GPU…
Wayne Gretzky’s enduring observation that hard work in youth can create freedom later is more than a hockey maxim. It is a compact description of how durable companies and long-term investor build advantage: do the unglamorous work early, develop pattern recognition before…
Consuelo Vanderbilt Costin’s new family office is a bullish signal for a market increasingly shaped by patient capital, powerful brands and investors willing to think beyond the next quarterly conference call. House of Vanderbilt begins modestly, but its ambitions sit squarely within…
The artificial-intelligence boom is often told through the familiar names of the computing stack—NVIDIA Corp. (NASDAQ: NVDA), Advanced Micro Devices Inc. (NASDAQ: AMD), Microsoft Corp. (NASDAQ: MSFT), Alphabet Inc. (NASDAQ: GOOGL), Amazon.com Inc. (NASDAQ: AMZN) and Meta Platforms Inc. (NASDAQ: META). But…
Doximity, Inc. (NYSE: DOCS) shares sold off into the close today but then staged a sharp rebound in the after‑hours session, with the stock surging more than 60 percent off its regular‑session levels as investors reassessed the company’s fiscal 2027 first‑quarter results…
